Catalyst Pharmaceuticals Inc (CPRX)
21.69
-1.11
(-4.87%)
USD |
NASDAQ |
Nov 14, 16:00
21.55
-0.14
(-0.65%)
After-Hours: 20:00
Catalyst Pharmaceuticals Cash and Short Term Investments (Quarterly): 442.33M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 442.33M |
| June 30, 2024 | 375.69M |
| March 31, 2024 | 310.41M |
| December 31, 2023 | 137.64M |
| September 30, 2023 | 120.97M |
| June 30, 2023 | 178.79M |
| March 31, 2023 | 148.25M |
| December 31, 2022 | 298.40M |
| September 30, 2022 | 256.06M |
| June 30, 2022 | 220.79M |
| March 31, 2022 | 197.80M |
| December 31, 2021 | 191.27M |
| September 30, 2021 | 174.79M |
| June 30, 2021 | 155.28M |
| March 31, 2021 | 143.30M |
| December 31, 2020 | 140.28M |
| September 30, 2020 | 127.11M |
| June 30, 2020 | 115.05M |
| March 31, 2020 | 101.75M |
| December 31, 2019 | 94.52M |
| September 30, 2019 | 76.54M |
| June 30, 2019 | 59.92M |
| March 31, 2019 | 45.63M |
| December 31, 2018 | 53.48M |
| September 30, 2018 | 61.66M |
| Date | Value |
|---|---|
| June 30, 2018 | 68.41M |
| March 31, 2018 | 77.94M |
| December 31, 2017 | 84.01M |
| September 30, 2017 | 33.91M |
| June 30, 2017 | 35.13M |
| March 31, 2017 | 36.53M |
| December 31, 2016 | 40.41M |
| September 30, 2016 | 44.74M |
| June 30, 2016 | 48.02M |
| March 31, 2016 | 52.45M |
| December 31, 2015 | 58.40M |
| September 30, 2015 | 62.96M |
| June 30, 2015 | 67.40M |
| March 31, 2015 | 71.54M |
| December 31, 2014 | 39.28M |
| September 30, 2014 | 41.45M |
| June 30, 2014 | 45.01M |
| March 31, 2014 | 21.28M |
| December 31, 2013 | 23.71M |
| September 30, 2013 | 27.65M |
| June 30, 2013 | 11.37M |
| March 31, 2013 | 13.16M |
| December 31, 2012 | 15.42M |
| September 30, 2012 | 11.97M |
| June 30, 2012 | 7.515M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
94.52M
Minimum
Dec 2019
442.33M
Maximum
Sep 2024
196.52M
Average
165.03M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 380.34M |
| Sarepta Therapeutics Inc | 1.198B |
| Alnylam Pharmaceuticals Inc | 2.780B |
| Biomarin Pharmaceutical Inc | 930.44M |
| Cytokinetics Inc | 1.012B |